E-Mail
WASHINGTON - The Society for Cardiovascular Angiography and Interventions (SCAI) presented its Master Interventionalists of SCAI (MSCAI) designations during the SCAI 2020 Scientific Sessions Virtual Conference MSCAI recognition ceremony.
The MSCAI designation is awarded to individuals who have demonstrated excellence in invasive/interventional cardiology over the course of their career and for their commitment to the highest levels of clinical care, innovation, publication, and teaching.
This year s MSCAI designations were awarded to the following group of outstanding interventionalists:
Ian C. Gilchrist, MD, MSCAI
Dr. Ian C. Gilchrist is a professor of medicine for Penn State University s College of Medicine at the Hershey Medical Center in Hershey, PA. Dr. Gilchrist graduated from Dartmouth College in Hanover, NH and then obtained his medical degree from Columbia University. He received his residency and cardiology fellowship training at the St. Luke s/Roosevelt Hospi
Target-Lesion Failure Reduced After MI With Biodegradable Stent
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
BASILICA Technique Prevents TAVR-Related Coronary Obstruction
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
MedStar Health wins $1 7M CDC contract to study Covid spread, vaccine adoption
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Large-scale study will track virus spread, vaccination rates in D.C. region
Lola Fadulu, The Washington Post
Dec. 22, 2020
FacebookTwitterEmail
Nurse Janelle Roper, left, administers the Pfizer coronavirus vaccine to Kristin Ta, a doctor at the Virginia Hospital Center in Arlington, last week.Washington Post photo by John McDonnell
A massive study announced Tuesday may help local health officials better track the spread of the novel coronavirus in the region and identify pockets of vaccine hesitancy.
The two-year study, led by researchers at MedStar Health and sponsored by the Centers for Disease Control and Prevention, appears to be one of the largest of its kind, health officials said. Researchers aim to recruit 60,000 participants, including those who haven t contracted the virus or received the vaccine.